Wouter E.M. Kok

4.5k total citations · 2 hit papers
69 papers, 2.9k citations indexed

About

Wouter E.M. Kok is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Wouter E.M. Kok has authored 69 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Cardiology and Cardiovascular Medicine, 19 papers in Surgery and 17 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Wouter E.M. Kok's work include Heart Failure Treatment and Management (23 papers), Chemotherapy-induced cardiotoxicity and mitigation (17 papers) and Childhood Cancer Survivors' Quality of Life (15 papers). Wouter E.M. Kok is often cited by papers focused on Heart Failure Treatment and Management (23 papers), Chemotherapy-induced cardiotoxicity and mitigation (17 papers) and Childhood Cancer Survivors' Quality of Life (15 papers). Wouter E.M. Kok collaborates with scholars based in Netherlands, Italy and Spain. Wouter E.M. Kok's co-authors include Yigal M. Pinto, Leontien C.M. Kremer, Allard C. van der Wal, Elvira C van Dalen, Helena J. H. van der Pal, Huib N. Caron, Flora E. van Leeuwen, Anke J. Tijsen, Perry D. Moerland and Esther E. Creemers and has published in prestigious journals such as Circulation, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Wouter E.M. Kok

64 papers receiving 2.8k citations

Hit Papers

MiR423-5p As a Circulating Biomarker for Heart Failure 2010 2026 2015 2020 2010 2015 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. MiR423-5p As a Circulating Biomarker for Heart Failure
    2010 530 citations Esther E. Creemers, Wouter E.M. Kok et al. profile →
  2. Cardiovascular Disease After Hodgkin Lymphoma Treatment
    2015 358 citations Frederika A. van Nimwegen, Michael Schaapveld et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wouter E.M. Kok Netherlands 26 1.8k 569 510 491 452 69 2.9k
Janine Nuver Netherlands 21 523 0.3× 391 0.7× 313 0.6× 332 0.7× 119 0.3× 70 1.8k
Patrick Collier United States 27 2.1k 1.2× 1.0k 1.8× 104 0.2× 456 0.9× 133 0.3× 106 3.2k
Mara Rubino Italy 18 1.4k 0.8× 684 1.2× 61 0.1× 316 0.6× 610 1.3× 58 2.6k
Juan Carlos Plana United States 30 5.5k 3.0× 732 1.3× 446 0.9× 819 1.7× 122 0.3× 63 6.3k
R M Bertina Netherlands 40 1.9k 1.0× 492 0.9× 272 0.5× 599 1.2× 360 0.8× 105 7.8k
Julia Meißner Germany 26 1.0k 0.6× 173 0.3× 138 0.3× 328 0.7× 62 0.1× 72 2.5k
Sanjeev Aggarwal United States 27 1.2k 0.6× 176 0.3× 229 0.4× 862 1.8× 46 0.1× 157 2.2k
Nihat Kalay Türkiye 27 1.6k 0.9× 266 0.5× 98 0.2× 529 1.1× 54 0.1× 96 2.6k
Michael G. Fradley United States 28 2.0k 1.1× 410 0.7× 72 0.1× 497 1.0× 78 0.2× 139 3.5k
Cezar Iliescu United States 27 2.3k 1.3× 516 0.9× 60 0.1× 639 1.3× 96 0.2× 175 3.8k

Countries citing papers authored by Wouter E.M. Kok

Since Specialization
Citations

This map shows the geographic impact of Wouter E.M. Kok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter E.M. Kok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter E.M. Kok more than expected).

Fields of papers citing papers by Wouter E.M. Kok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wouter E.M. Kok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter E.M. Kok. The network helps show where Wouter E.M. Kok may publish in the future.

Co-authorship network of co-authors of Wouter E.M. Kok

This figure shows the co-authorship network connecting the top 25 collaborators of Wouter E.M. Kok. A scholar is included among the top collaborators of Wouter E.M. Kok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wouter E.M. Kok. Wouter E.M. Kok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meregalli, Paola G., M. Louis Handoko, Susan Stienen, et al.. (2024). Digital consults in heart failure care: a randomized controlled trial. Nature Medicine. 30(10). 2907–2913. 11 indexed citations
2.
Kuipers, Maria T., Anne M. Spanjaart, Francesca Bonifazi, et al.. (2023). Feasibility of CD19 CAR T-cell therapy in patients with cardiac lymphoma. Leukemia & lymphoma. 65(3). 399–402.
3.
Man, Frances S. de, Wouter E.M. Kok, Patrick N.A. Bronzwaer, et al.. (2023). Trimetazidine in Heart Failure with Preserved Ejection Fraction: A Randomized Controlled Cross-Over Trial. ESC Heart Failure. 10(5). 2998–3010. 20 indexed citations
4.
Leerink, Jan M., Elizabeth A. M. Feijen, Leontien C.M. Kremer, et al.. (2021). Extracellular matrix remodeling in animal models of anthracycline-induced cardiomyopathy: a meta-analysis. Journal of Molecular Medicine. 99(9). 1195–1207. 6 indexed citations
5.
Bakermans, Adrianus J., Cornelis P. Allaart, Aart J. Nederveen, et al.. (2020). TrimetaziDine as a Performance-enhancING drug in heart failure with preserved ejection fraction (DoPING-HFpEF): rationale and design of a placebo-controlled cross-over intervention study. Netherlands Heart Journal. 28(6). 312–319. 12 indexed citations
6.
Vries, Simone de, Michael Schaapveld, Frederika A. van Nimwegen, et al.. (2018). High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors. British Journal of Cancer. 118(6). 887–895. 11 indexed citations
7.
Dijk, Irma W.E.M. van, J. Visser, Brian V. Balgobind, et al.. (2018). Heart volume reduction during radiotherapy involving the thoracic region in children: An unexplained phenomenon. Radiotherapy and Oncology. 128(2). 214–220. 1 indexed citations
8.
Stienen, Susan, Khibar Salah, Arno H. Moons, et al.. (2017). NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure. Circulation. 137(16). 1671–1683. 101 indexed citations
9.
Stienen, Susan, Khibar Salah, Luc W.M. Eurlings, et al.. (2016). Targeting N-Terminal Pro-Brain Natriuretic Peptide in Older Versus Younger Acute Decompensated Heart Failure Patients. JACC Heart Failure. 4(9). 736–745. 10 indexed citations
10.
11.
12.
13.
Eurlings, Luc W.M., Wouter E.M. Kok, Aggie H.M.M. Balk, et al.. (2010). Management of Chronic Heart Failure Guided by Individual N-Terminal Pro–B-Type Natriuretic Peptide Targets. Journal of the American College of Cardiology. 56(25). 2090–2100. 140 indexed citations
14.
Sankatsing, Sanjay U. C., et al.. (2008). Recurrent acute pulmonary oedema after aortic and mitral valve surgery due to trachea malacia and obstructive sleep apnoea syndrome. Netherlands Heart Journal. 16(9). 310–312. 1 indexed citations
15.
Dalen, Elvira C van, Helena J. H. van der Pal, Wouter E.M. Kok, Huib N. Caron, & Leontien C.M. Kremer. (2006). Clinical heart failure in a cohort of children treated with anthracyclines: A long-term follow-up study. European Journal of Cancer. 42(18). 3191–3198. 205 indexed citations
16.
17.
Kok, Wouter E.M., Ron J.G. Peters, Gerard Pasterkamp, et al.. (2000). Greater late lumen loss after successful coronary balloon angioplasty in the proximal left anterior descending coronary artery is not explained by extent of vessel wall damage or plaque burden. Journal of the American College of Cardiology. 35(2). 382–388. 2 indexed citations
18.
Chamuleau, Steven A. J., Jan J. Piek, Yolande Appelman, et al.. (1998). An analogue laser optical disc in comparison with cinefilm for visual analysis of coronary narrowings before and after coronary angioplasty. International journal of cardiac imaging. 14(1). 19–26. 1 indexed citations
19.
Peters, Ron J.G., Wouter E.M. Kok, H. Rijsterborgh, et al.. (1996). Reproducibility of quantitative measurements from intracoronary ultrasound images: Beat-to-beat variability and influence of the cardiac cycle. European Heart Journal. 17(10). 1593–1599. 26 indexed citations
20.
Peters, Ron J.G., Wouter E.M. Kok, Hans Bot, & Cees A. Visser. (1994). Characterization of Plaque Components With Intracoronary Ultrasound Imaging: An In Vitro Quantitative Study With Videodensitometry. Journal of the American Society of Echocardiography. 7(6). 616–623. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janine Nuver Breakdown of academic impact, for papers by Patrick Collier Breakdown of academic impact, for papers by Mara Rubino Breakdown of academic impact, for papers by Juan Carlos Plana Breakdown of academic impact, for papers by R M Bertina Breakdown of academic impact, for papers by Julia Meißner Breakdown of academic impact, for papers by Sanjeev Aggarwal Breakdown of academic impact, for papers by Nihat Kalay Breakdown of academic impact, for papers by Michael G. Fradley Breakdown of academic impact, for papers by Cezar Iliescu
Rankless by CCL
2026